Why Spark Therapeutics Is Up Over 50%
Spark Therapeutics made history Monday morning when it announced successful Phase 3 results in gene therapy for a genetic disease.
All Work
Chris Lange
Top 7 Earnings to Look For in the Week Ahead
24/7 Wall St. has put together a preview Alcoa, PepsiCo and other major companies reporting their quarterly results this week.
5 Big FDA Decisions Expected in October
24/7 Wall St. has collected several big FDA decisions coming up on the calendar for the month of October and added some color.
SEC Finds 22 Underwriting Firms in Violation of MCDC Initiative
The U.S. Securities and Exchange Commission has taken enforcement actions against 22 municipal underwriting firms for violations in municipal bond offerings.
SEC Freezes Assets in Alleged Amber Scheme
The SEC has announced that it has filed fraud charges and obtained asset freezes against the operator of a worldwide pyramid scheme.
Why Oppenheimer Sees Google Accelerating
Oppenheimer upgraded Google to an Outperform rating and raised its price target to $700, implying upside of more than 15% from current prices.
Why Canaccord Genuity Sees Intel Rising Over 30% Despite Sell-Off
Canaccord Genuity reiterated a Buy rating with a price target that implies upside of more than 30%, one of the most bullish calls on the stock.
SEC Charges NJ Fund Manager for Defrauding Investors
According to the SEC’s complaint filed in federal court in Manhattan, William J. Wells falsely told some investors that he was a registered investment adviser and would invest their money in specific stocks.
Micron Soars on Solid Earnings Beat
ThinkstockMicron Technology, Inc. (NASDAQ: MU) reported its fiscal fourth quarter financial results after the markets closed on Thursday. The company had $0.37 in earnings per share (EPS) on $3.6 billion in revenue compared to…
Amaya Gets Dealt a Winning Hand With NJ Authorization
ThinkstockIt appears that Amaya, Inc. (NASDAQ: AYA) was dealt a winning hand, considering how its shares are performing in the market on Thursday. This move came after the company announced that the New Jersey…
Pacific Biosciences Surges on New System
Pacific Biosciences of California was surging in the market on Thursday despite a sharp downturn in the health care sector over the past quarter.
First Data Sets Terms for IPO
First Data is offering 160 million shares at an expected price range of $18 to $20 in an IPO valued up to $3.68 billion.
Surgery Partners Enters Market Well Below Expected Range
Surgery Partners entered the market on Thursday in its initial public offering priced under the expected range.
Performance Food Limps Into the Market in IPO
Performance Food Group entered the market on Thursday morning in its initial public offering well below the expected price range.
5 Top Oppenheimer Oil Service Stocks to Buy for Double-Dip in Rig Activity
Oppenheimer believes that in the long run oil prices are unsustainable at these levels, and there are several catalysts that could present negative headwinds over the next several weeks.
Pure Storage Sets Terms for IPO
Pure Storage expects to price 25 million shares within the range of $16 to $18 in an IPO valued up to $517 million.
Why Key Analyst Sees 30% Upside in Western Digital
Argus raised its rating on Western Digital to Buy from Hold and set a target price that implies upside of almost 30% from current prices.
Sarepta Makes Headway With Phase 2 Program
Sarepta Therapeutics announced additional clinical efficacy and safety data from its Phase 2b program of eteplirsen in patients with Duchenne muscular dystrophy.
Mirna Therapeutics Sets IPO Price
ThinkstockMirna Therapeutics has filed an amended S-1 form with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO). Some 6.25 million shares are being offered, with an overallotment option for…
What to Expect From Micron Earnings
ThinkstockMicron Technology, Inc. (NASDAQ: MU) is scheduled to report its fiscal fourth quarter financial results after the markets close on Thursday. The consensus estimates from Thomson Reuters call for $0.33 in earnings per share…